CD4+ T-cell activation of bone marrow causes bone fragility and insulin resistance in type 2 diabetes

Bone ◽  
2021 ◽  
pp. 116292
Author(s):  
S.E. Cifuentes-Mendiola ◽  
D.L. Solis-Suarez ◽  
A. Martínez-Dávalos ◽  
M. Godínez-Victoria ◽  
A.L. García-Hernández
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Bone Marrow ◽  
T Cell ◽  
T Cell Activation ◽  
Cell Activation ◽  
Bone Fragility ◽  
Cd4 T Cell

Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation

2010 ◽  
Vol 24 (3) ◽  
pp. 209-213 ◽  
Author(s):  
Perrin C. White ◽  
Heidi Chamberlain-Shea ◽  
Maria-Teresa de la Morena
Keyword(s):  
Type 2 Diabetes ◽  
T Cell ◽  
T Cell Activation ◽  
Cell Activation ◽  
Cd4 T Cell

T-cell activation and cardiovascular risk in adults with type 2 diabetes mellitus: A systematic review and meta-analysis

2020 ◽  
Vol 210 ◽  
pp. 108313 ◽  
Author(s):  
Tawanda Maurice Nyambuya ◽  
Phiwayinkosi Vusi Dludla ◽  
Vuyolwethu Mxinwa ◽  
Bongani Brian Nkambule
Keyword(s):  
Diabetes Mellitus ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
T Cell ◽  
T Cell Activation ◽  
Cell Activation ◽  
Meta Analysis

scholarly journals The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+ T cell activation

2013 ◽  
Vol 86 (6) ◽  
pp. 770-781 ◽  
Author(s):  
Andrew J. Wiemer ◽  
Sarah A. Wernimont ◽  
Thai-duong Cung ◽  
David A. Bennin ◽  
Hilary E. Beggs ◽  
...  
Keyword(s):  
T Cell ◽  
Focal Adhesion Kinase ◽  
Focal Adhesion ◽  
T Cell Activation ◽  
Cell Activation ◽  
Kinase Inhibitor ◽  
Cd4 T Cell
Sign in / Sign up

Export Citation Format

Share Document